Preeclampsia: a gestational cardiorenal syndrome

Wilfried Gyselaers, Basky Thilaganathan, Wilfried Gyselaers, Basky Thilaganathan

Abstract

It is generally accepted today that there are two different types of preeclampsia: an early-onset or placental type and a late-onset or maternal type. In the latent phase, the first one presents with a low output/high resistance circulation eventually leading in the late second or early third trimester to an intense and acutely aggravating systemic disorder with an important impact on maternal and neonatal mortality and morbidity; the other type presents initially as a high volume/low resistance circulation, gradually evolving to a state of circulatory decompensation usually in the later stages of pregnancy, with a less severe impact on maternal and neonatal outcome. For both processes, numerous dysfunctions of the heart, kidneys, arteries, veins and interconnecting systems are reported, most of them presenting earlier and more severely in early- than in late-onset preeclampsia; however, some very specific dysfunctions exist for either type. Experimental, clinical and epidemiological observations before, during and after pregnancy are consistent with gestation-induced worsening of subclinical pre-existing chronic cardiovascular dysfunction in early-onset preeclampsia, and thus sharing the pathophysiology of cardiorenal syndrome type II, and with acute volume overload decompensation of the maternal circulation in late-onset preeclampsia, thus sharing the pathophysiology of cardiorenal syndrome type 1. Cardiorenal syndrome type V is consistent with the process of preeclampsia superimposed upon clinical cardiovascular and/or renal disease, alone or as part of a systemic disorder. This review focuses on the specific differences in haemodynamic dysfunctions between the two types of preeclampsia, with special emphasis on the interorgan interactions between heart and kidneys, introducing the theoretical concept that the pathophysiological processes of preeclampsia can be regarded as the gestational manifestations of cardiorenal syndromes.

Keywords: cardiorenal syndrome; early onset preeclampsia; late onset preeclampsia; maternal hemodynamics; preeclampsia.

© 2019 The Authors. The Journal of Physiology © 2019 The Physiological Society.

References

    1. AbdAlla S, Lother H, el Massiery A & Quitterer U (2001). Increased AT1 receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nat Med 7, 1003-1009.
    1. Akcay A, Nguyen Q & Edelstein CL (2009). Mediators of inflammation in acute kidney injury. Mediators Inflamm 2009, 137072.
    1. Al-Balas M, Bozzo P & Einarson A (2009). Use of diuretics during pregnancy. Can Fam Physician 55, 44-45.
    1. Álvarez-Fernández I, Prieto B, Rodríguez V, Ruano Y, Escudero AI,& Álvarez FV (2016). N-terminal pro B-type natriuretic peptide and angiogenic biomarkers in the prognosis of adverse outcomes in women with suspected preeclampsia. Clin Chim Acta 463, 150-157.
    1. Andrietti S, Kruse AJ, Bekkers SC, Sep S, Spaanderman M & Peeters LL (2008). Cardiac adaptation to pregnancy in women with a history of preeclampsia and a subnormal plasma volume. Reprod Sci 15, 1059-1065.
    1. Angeli E, Verdecchia P, Narducci P & Angeli F (2011). Additive value of standard ECG for the risk prediction of hypertensive disorders during pregnancy. Hypertens Res 34, 707-713.
    1. Angeli F, Angeli E & Verdecchia P (2015). Novel electrocardiographic patterns for the prediction of hypertensive disorders of pregnancy-from pathophysiology to practical implications. Int J Mol Sci 16, 18454-18473.
    1. Anim-Nyame N, Gamble J, Sooranna SR, Johnson MR, Sullivan MH & Steer PJ (2003). Evidence of impaired microvascular function in pre-eclampsia: a non-invasive study. Clin Sci (Lond) 104, 405-412.
    1. Anim-Nyame N, Sooranna SR, Johnson MR, Sullivan MH, Gamble J & Steer PJ (2004). Impaired retrograde transmission of vasodilatory signals via the endothelium in pre-eclampsia: a cause of reduced tissue blood flow? Clin Sci (Lond) 106, 19-25.
    1. Anton L & Brosnihan KB (2008). Systemic and uteroplacental renin-angiotensin system in normal and pre-eclamptic pregnancies. Ther Adv Cardiovasc Dis 2, 349-362.
    1. Austdal M, Skråstad RB, Gundersen AS, Austgulen R, Iversen AC & Bathen TF (2014). Metabolomic biomarkers in serum and urine in women with preeclampsia. PLoS One 9, e91923.
    1. Bartsch E, Medcalf KE, Park AL & Ray JG; High Risk of Pre-eclampsia Identification Group (2016). Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies. BMJ 353, i1753.
    1. Bateman GA, Giles W & England SL (2004). Renal venous Doppler sonography in preeclampsia. J Ultrasound Med 23, 1607-1611.
    1. Bauersachs J & Schäfer A (2004). Endothelial dysfunction in heart failure: mechanisms and therapeutic approaches. Curr Vasc Pharmacol 2, 115-124.
    1. Baumert M, Seeck A, Faber R, Nalivaiko E & Voss A (2010). Longitudinal changes in QT interval variability and rate adaptation in pregnancies with normal and abnormal uterine perfusion. Hypertens Res 33, 555-560.
    1. Baumfeld Y, Novack L, Wiznitzer A, Sheiner E, Henkin Y, Sherf M & Novack V (2015). Pre-conception dyslipidemia is associated with development of preeclampsia and gestational diabetes mellitus. PLoS One 10, e0139164.
    1. Behrens I, Basit S, Melbye M, Lykke JA, Wohlfahrt J, Bundgaard H, Thilaganathan B & Boyd HA (2017). Risk of post-pregnancy hypertension in women with a history of hypertensive disorders of pregnancy: nationwide cohort study. BMJ 358, j3078.
    1. Bekheirnia MR & Schrier RW (2006). Pathophysiology of water and sodium retention: edematous states with normal kidney function. Curr Opin Pharmacol 6, 202-207.
    1. Bijl RC, Valensise H, Novelli GP, Vasapollo B, Wilkinson I, Thilaganathan B, Stöhr EJ, Lees C, van der Marel CD & Cornette JMJ; International Working Group on Maternal Hemodynamics (2019). Methods and considerations concerning cardiac output measurement in pregnant women: recommendations of the International Working Group on Maternal Hemodynamics. Ultrasound Obstet Gynecol 54, 35-50.
    1. Blake P, Hasegawa Y, Khosla MC, Fouad-Tarazi F, Sakura N & Paganini EP (1996). Isolation of “myocardial depressant factor(s)” from the ultrafiltrate of heart failure patients with acute renal failure. ASAIO J 42, M911-M915.
    1. Boeldt DS & Bird IM (2017). Vascular adaptation in pregnancy and endothelial dysfunction in preeclampsia. J Endocrinol 232, R27-R44.
    1. Bongartz LG, Cramer MJ, Doevendans PA, Joles JA & Braam B (2005). The severe cardiorenal syndrome: ‘Guyton revisited’. Eur Heart J 26, 11-17.
    1. Bonventre JV (2003). Dedifferentiation and proliferation of surviving epithelial cells in acute renal failure. J Am Soc Nephrol 14, S55-S61.
    1. Borges VTM, Zanati SG, Peraçoli MTS, Poiati JR, Romão-Veiga M, Peraçoli JC & Thilaganathan B (2018). Maternal left ventricular hypertrophy and diastolic dysfunction and brain natriuretic peptide concentration in early- and late-onset pre-eclampsia. Ultrasound Obstet Gynecol 51, 519-523.
    1. Borghi C, Verardi FM, Pareo I, Bentivenga C & Cicero AF (2014). Hyperuricemia and cardiovascular disease risk. Expert Rev Cardiovasc Ther 12, 1219-1225.
    1. Bosio PM, McKenna PJ, Conroy R & O'Herlihy C (1999). Maternal central hemodynamics in hypertensive disorders of pregnancy. Obstet Gynecol 94, 978-984.
    1. Brosens JJ, Pijnenborg R & Brosens IA (2002). The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: a review of the literature. Am J Obstet Gynecol 187, 1416-1423.
    1. Brown CM & Garovic VD (2014). Drug treatment of hypertension in pregnancy. Drugs 74, 283-296.
    1. Bryant D, Becker L, Richardson J, Shelton J, Franco F, Peshock R, Thompson M & Giroir B (1998). Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. Circulation 97, 1375-1381.
    1. Buddeberg BS, Sharma R, O'Driscoll JM, Kaelin Agten A, Khalil A & Thilaganathan B (2018a). Cardiac maladaptation in term pregnancies with preeclampsia. Pregnancy Hypertens 13, 198-203.
    1. Buddeberg BS, Sharma R, O'Driscoll JM, Kaelin Agten A, Khalil A & Thilaganathan B (2018b). Cardiac maladaptation in obese pregnancy at term. Ultrasound Obstet Gynecol . [Epub ahead of print].
    1. Burnett LA & Nowak RA (2016). Exosomes mediate embryo and maternal interactions at implantation and during pregnancy. Front Biosci (Schol Ed) 8, 79-96.
    1. Burton GJ (2009). Oxygen, the Janus gas; its effects on human placental development and function. J Anat 215, 27-35.
    1. Cacciatore B, Halmesmäki E, Kaaja R, Teramo K & Ylikorkala O (1998). Effects of transdermal nitroglycerin on impedance to flow in the uterine, umbilical, and fetal middle cerebral arteries in pregnancies complicated by preeclampsia and intrauterine growth retardation. Am J Obstet Gynecol 179, 140-145.
    1. Çağlar FN, Ozde C, Bostancı E, Çağlar İM, Çiftçi S, Unğan İ, Demir B & Karakaya O (2016). Assessment of right heart function in preeclampsia by echocardiography. Pregnancy Hypertens 6, 89-94.
    1. Carr DB, Gavrila D, Brateng D & Easterling TR (2007). Maternal hemodynamic changes associated with furosemide treatment. Hypertens Pregnancy 26, 173-178.
    1. Castleman JS, Ganapathy R, Taki F, Lip GY, Steeds RP & Kotecha D (2016). Echocardiographic structure and function in hypertensive disorders of pregnancy: a systematic review. Circ Cardiovasc Imaging 9, e004888.
    1. Cetin A, Yurtcu N, Guvenal T, Imir AG, Duran B & Cetin M (2004). The effect of glyceryl trinitrate on hypertension in women with severe preeclampsia, HELLP syndrome, and eclampsia. Hypertens Pregnancy 23, 37-46.
    1. Chapman AB, Abraham WT, Zamudio S, Coffin C, Merouani A, Young D, Johnson A, Osorio F, Goldberg C, Moore LG, Dahms T & Schrier RW (1998). Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. Kidney Int 54, 2056-2063.
    1. Charolidi N, Host AJ, Ashton S, Tryfonos Z, Leslie K, Thilaganathan B, Cartwright JE & Whitley GS (2019). First trimester placental endothelial cells from pregnancies with abnormal uterine artery Doppler are more sensitive to apoptotic stimuli. Lab Invest 99, 411-420.
    1. Chen X, Man GCW, Liu Y, Wu F, Huang J, Li TC & Wang CC (2017). Physiological and pathological angiogenesis in endometrium at the time of embryo implantation. Am J Reprod Immunol 78, e12693.
    1. Chun R & Kirkpatrick AW (2012). Intra-abdominal pressure, intra-abdominal hypertension, and pregnancy: a review. Ann Intensive Care 2, S5.
    1. Colombo PC, Ganda A, Lin J, Onat D, Harxhi A, Iyasere JE, Uriel N & Cotter G (2012). Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome. Heart Fail Rev 17, 177-190.
    1. Cong J, Fan T, Yang X, Shen J, Cheng G & Zhang Z (2015). Maternal cardiac remodeling and dysfunction in preeclampsia: a three-dimensional speckle-tracking echocardiography study. Int J Cardiovasc Imaging 31, 1361-1368.
    1. Conrad KP & Davison JM (2014). The renal circulation in normal pregnancy and preeclampsia: is there a place for relaxin? Am J Physiol Renal Physiol 306, F1121-F1135.
    1. Cotton DB, Jones MM, Longmire S, Dorman KF, Tessem J & Joyce TH 3rd (1986). Role of intravenous nitroglycerin in the treatment of severe pregnancy-induced hypertension complicated by pulmonary edema. Am J Obstet Gynecol 154, 91-93.
    1. Craici IM, Wagner SJ, Weissgerber TL, Grande JP & Garovic VD (2014). Advances in the pathophysiology of pre-eclampsia and related podocyte injury. Kidney Int 86, 275-285.
    1. Damman K, van Deursen VM, Navis G, Voors AA, van Veldhuisen DJ & Hillege HL (2009). Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol 53, 582-588.
    1. Davison JM (1997). Edema in pregnancy. Kidney Int Suppl 59, S90-S96.
    1. De Deyn PP, Vanholder R & D'Hooge R (2003). Nitric oxide in uremia: effects of several potentially toxic guanidino compounds. Kidney Int Suppl 84, S25-S28.
    1. de Haas S, Ghossein-Doha C, van Kuijk SM, van Drongelen J & Spaanderman ME (2017). Physiological adaptation of maternal plasma volume during pregnancy: a systematic review and meta-analysis. Ultrasound Obstet Gynecol 49, 177-187.
    1. De Wolf F, Brosens I & Robertson WB (1982). Ultrastructure of uteroplacental arteries. Contrib Gynecol Obstet 9, 86-99.
    1. Di Lullo L, Bellasi A, Barbera V, Russo D, Russo L, Di Iorio B, Cozzolino M & Ronco C (2017). Pathophysiology of the cardio-renal syndromes types 1-5: an uptodate. Indian Heart J 69, 255-265.
    1. Duvekot JJ, Cheriex EC, Pieters FA, Menheere PP & Peeters LH (1993). Early pregnancy changes in hemodynamics and volume homeostasis are consecutive adjustments triggered by a primary fall in systemic vascular tone. Am J Obstet Gynecol 169, 1382-1392.
    1. Easterling TR, Benedetti TJ, Schmucker BC & Millard SP (1990). Maternal hemodynamics in normal and preeclamptic pregnancies: a longitudinal study. Obstet Gynecol 76, 1061-1069
    1. Elmore S (2007). Apoptosis: a review of programmed cell death. Toxicol Pathol 35, 495-516.
    1. Fakhouri F, Vercel C & Frémeaux-Bacchi V (2012). Obstetric nephrology: AKI and thrombotic microangiopathies in pregnancy. Clin J Am Soc Nephrol 7, 2100-2106.
    1. Falco ML, Sivanathan J, Laoreti A, Thilaganathan B & Khalil A (2017). Placental histopathology associated with pre-eclampsia: systematic review and meta-analysis. Ultrasound Obstet Gynecol 50, 295-301.
    1. Ferrazzi E, Stampalija T, Monasta L, Di Martino D, Vonck S & Gyselaers W (2018). Maternal hemodynamics: a method to classify hypertensive disorders of pregnancy. Am J Obstet Gynecol 218, 124.e1-124.e11.
    1. Finnerty NM, Panchal AR, Boulger C, Vira A, Bischof JJ, Amick C, Way DP & Bahner DP (2017) Inferior vena cava measurement with ultrasound: what is the best view and best mode? West J Emerg Med 18, 496-501.
    1. Fischer-Betz R & Specker C (2017). Pregnancy in systemic lupus erythematosus and antiphospholipid syndrome. Best Pract Res Clin Rheumatol 31, 397-414.
    1. Foo FL, Mahendru AA, Masini G, Fraser A, Cacciatore S, MacIntyre DA, McEniery CM, Wilkinson IB, Bennett PR & Lees CC (2018). Association between prepregnancy cardiovascular function and subsequent preeclampsia or fetal growth restriction. Hypertension 72, 442-450.
    1. Franz MB, Burgmann M, Neubauer A, Zeisler H, Sanani R, Gottsauner-Wolf M, Schiessl B & Andreas M (2013). Augmentation index and pulse wave velocity in normotensive and pre-eclamptic pregnancies. Acta Obstet Gynecol Scand 92, 960-966.
    1. Friedberg V & Lutz J (1963). Studies on capillary permeability in pregnancy. A contribution to the cause of proteinuria in toxemias. Arch Gynakol 199, 96-106.
    1. Fu Q, Cao L, Li H, Wang B & Li Z (2014). Cardiorenal syndrome: pathophysiological mechanism, preclinical models, novel contributors and potential therapies. Chin Med J (Engl) 127, 3011-3018.
    1. Funk DJ, Jacobsohn E & Kumar A (2013). The role of venous return in critical illness and shock-part I: physiology. Crit Care Med 41, 255-262.
    1. Galley HF & Webster NR (2004). Physiology of the endothelium. Br J Anaesth 93, 105-113.
    1. Gallos ID, Sivakumar K, Kilby MD, Coomarasamy A, Thangaratinam S & Vatish M (2013). Pre-eclampsia is associated with, and preceded by, hypertriglyceridaemia: a meta-analysis. BJOG 120, 1321-1332.
    1. García-Donaire JA & Ruilope LM (2011). Cardiovascular and renal links along the cardiorenal continuum. Int J Nephrol 2011, 975782.
    1. Ghi T, degli Esposti D, Montaguti E, Rosticci M, Tancredi S, Youssef A, di Giovanni MV, Pilu G, Borghi C & Rizzo N (2015). Maternal cardiac evaluation during uncomplicated twin pregnancy with emphasis on the diastolic function. Am J Obstet Gynecol 213, 376.e1-376.e8.
    1. Gottlieb SS, Fisher ML, Pressel MD, Patten RD, Weinberg M & Greenberg N (1993). Effects of intravenous magnesium sulfate on arrhythmias in patients with congestive heart failure. Am Heart J 125, 1645-1650.
    1. Grunewald C, Kublickas M, Carlström K, Lunell NO & Nisell H (1995). Effects of nitroglycerin on the uterine and umbilical circulation in severe preeclampsia. Obstet Gynecol 86, 600-604.
    1. Guo HX, Zhu YB, Wu CP, Zhong M & Hu SW (2019). Potential urine biomarkers for gestational hypertension and preeclampsia. Mol Med Rep 19, 2463-2470.
    1. Gyselaers W, Mesens T, Tomsin K, Molenberghs G & Peeters L (2010). Maternal renal interlobar vein impedance index is higher in early- than in late-onset pre-eclampsia. Ultrasound Obstet Gynecol 36, 69-75.
    1. Gyselaers W, Mullens W, Tomsin K, Mesens T & Peeters L (2011). Role of dysfunctional maternal venous hemodynamics in the pathophysiology of pre-eclampsia: a review. Ultrasound Obstet Gynecol 38, 123-129.
    1. Gyselaers W, Tomsin K, Staelens A, Mesens T, Oben J & Molenberghs G (2014). Maternal venous hemodynamics in gestational hypertension and preeclampsia. BMC Pregnancy Childbirth 14, 212.
    1. Gyselaers W, Vonck S, Staelens AS, Lanssens D, Tomsin K, Oben J, Dreesen P & Bruckers L (2018). Body fluid volume homeostasis is abnormal in pregnancies complicated with hypertension and/or poor fetal growth. PLoS One 13, e0206257.
    1. Gyselaers WJ, Vonck S, Staelens ASE, Lanssens D, Tomsin K, Oben J, Dreesen P & Bruckers L (2019). Gestational hypertensive disorders show unique patterns of circulatory deterioration with ongoing pregnancy. Am J Physiol Regul Integr Comp Physiol 316, R210-R221.
    1. Hadid V, Patenaude V, Oddy L & Abenhaim HA (2015). Sarcoidosis and pregnancy: obstetrical and neonatal outcomes in a population-based cohort of 7 million births. J Perinat Med 43, 201-207.
    1. Hanada S, Takewa Y, Mizuno T, Tsukiya T, Taenaka Y & Tatsumi E (2012). Effect of the technique for assisting renal blood circulation on ischemic kidney in acute cardiorenal syndrome. J Artif Organs 15, 140-145.
    1. Harnett JD, Foley RN, Kent GM, Barre PE, Murray D & Parfrey PS (1995). Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int 47, 884-890.
    1. Havasi A & Borkan SC (2011). Apoptosis and acute kidney injury. Kidney Int 80, 29-40.
    1. Hayashi M, Ueda Y, Hoshimoto K, Ota Y, Fukasawa I, Sumori K, Kaneko I, Abe S, Uno M, Ohkura T & Inaba N (2002). Changes in urinary excretion of six biochemical parameters in normotensive pregnancy and preeclampsia. Am J Kidney Dis 39, 392-400.
    1. Henao DE, Saleem MA & Cadavid AP (2010). Glomerular disturbances in preeclampsia: disruption between glomerular endothelium and podocyte symbiosis. Hypertens Pregnancy 29, 10-20.
    1. Herse F, Verlohren S, Wenzel K, Pape J, Muller DN, Modrow S, Wallukat G, Luft FC, Redman CW & Dechend R (2009). Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study. Hypertension 53, 393-398.
    1. Hladunewich M, Karumanchi SA & Lafayette R (2007). Pathophysiology of the clinical manifestations of preeclampsia. Clin J Am Soc Nephrol 2, 543-549.
    1. Huppertz B, Weiss G & Moser G (2014). Trophoblast invasion and oxygenation of the placenta: measurements versus presumptions. J Reprod Immunol 101-102, 74-79.
    1. Ilyas A, Ishtiaq W, Assad S, Ghazanfar H, Mansoor S, Haris M, Qadeer A & Akhtar A (2017). Correlation of IVC diameter and collapsibility index with central venous pressure in the assessment of intravascular volume in critically ill patients. Cureus 9, e1025.
    1. Ince C, Schulman SP, Quigley JF, Berger RD, Kolasa M, Ferguson R, Silver B & Haigney MC (2001). Usefulness of magnesium sulfate in stabilizing cardiac repolarization in heart failure secondary to ischemic cardiomyopathy. Am J Cardiol 88, 224-229.
    1. Inci S, Nar G, Aksan G, Sipahioğlu H, Soylu K & Dogan A (2015). P-wave dispersion and atrial electromechanical delay in patients with preeclampsia. Med Princ Pract 24, 515-521.
    1. Irani RA & Xia Y (2008). The functional role of the renin-angiotensin system in pregnancy and preeclampsia. Placenta 29, 763-771.
    1. Irani RA & Xia Y (2011). Renin angiotensin signaling in normal pregnancy and preeclampsia. Semin Nephrol 31, 47-58.
    1. James-Allan LB, Whitley GS, Leslie K, Wallace AE & Cartwright JE (2018). Decidual cell regulation of trophoblast is altered in pregnancies at risk of pre-eclampsia. J Mol Endocrinol 60, 239-246.
    1. Jeffcoate TN (1966). Pre-eclampsia and eclampsia: the disease of theories. Proc R Soc Med 59, 397-404.
    1. Jeyabalan A & Conrad KP (2007). Renal function during normal pregnancy and preeclampsia. Front Biosci 12, 2425-2437.
    1. Jim B, Mehta S, Qipo A, Kim K, Cohen HW, Moore RM, He JC & Sharma S (2014). A comparison of podocyturia, albuminuria and nephrinuria in predicting the development of preeclampsia: a prospective study. PLoS One 9, e101445.
    1. Jin WY, Lin SL, Hou RL, Chen XY, Han T, Jin Y, Tang L, Zhu ZW & Zhao ZY (2016). Associations between maternal lipid profile and pregnancy complications and perinatal outcomes: a population-based study from China. BMC Pregnancy Childbirth 16, 60.
    1. Johal T, Lees CC, Everett TR & Wilkinson IB (2014). The nitric oxide pathway and possible therapeutic options in pre-eclampsia. Br J Clin Pharmacol 78, 244-257.
    1. Johnson RJ & Nangaku M (2016). Endothelial dysfunction: the secret agent driving kidney disease. J Am Soc Nephrol 27, 3-5.
    1. Jung YJ, Cho HY, Cho S, Kim YH, Jeon JD, Kim YJ, Lee S, Park J, Kim HY, Park YW & Kwon JY (2017). The level of serum and urinary nephrin in normal pregnancy and pregnancy with subsequent preeclampsia. Yonsei Med J 58, 401-406.
    1. Kajimoto K, Sato N, Keida T, Sakata Y & Takano T; Acute Decompensated Heart Failure Syndromes (ATTEND) Investigators (2014). Associations of anemia and renal dysfunction with outcomes among patients hospitalized for acute decompensated heart failure with preserved or reduced ejection fraction. Clin J Am Soc Nephrol 9, 1912-1921.
    1. Kalafat E, Laoreti A, Khalil A, Da Silva Costa F & Thilaganathan B (2018). Ophthalmic artery Doppler for prediction of pre-eclampsia: systematic review and meta-analysis. Ultrasound Obstet Gynecol 51, 731-737.
    1. Kalafat E & Thilaganathan B (2017). Cardiovascular origins of preeclampsia. Curr Opin Obstet Gynecol 29, 383-389.
    1. Karabulut N, Baki Yağci A & Karabulut A (2003). Renal vein Doppler ultrasound of maternal kidneys in normal second and third trimester pregnancy. Br J Radiol 76, 444-447.
    1. Keller G, Zimmer G, Mall G, Ritz E & Amann K(2003). Nephron number in patients with primary hypertension. N Engl J Med 348, 101-108.
    1. Kelly KJ (2003). Distant effects of experimental renal ischemia/reperfusion injury. J Am Soc Nephrol 14, 1549-1558.
    1. Keyrouz SG & Diringer MN (2007). Clinical review: prevention and therapy of vasospasm in subarachnoid hemorrhage. Crit Care 11, 220.
    1. Khalil A, Garcia-Mandujano R, Maiz N, Elkhouli M & Nicolaides KH (2014a). Longitudinal changes in uterine artery Doppler and blood pressure and risk of pre-eclampsia. Ultrasound Obstet Gynecol 43, 541-547. Erratum: Ultrasound Obstet Gynecol 44, 244.
    1. Khalil A, Garcia-Mandujano R, Maiz N, Elkhouli M & Nicolaides KH (2014b). Longitudinal changes in maternal hemodynamics in a population at risk for pre-eclampsia. Ultrasound Obstet Gynecol 44, 197-204.
    1. Kingma JG Jr, Vincent C, Rouleau JR & Kingma I (2006). Influence of acute renal failure on coronary vasoregulation in dogs. J Am Soc Nephrol 17, 1316-1324.
    1. Kirbas A, Kirbas O, Daglar K, Inal HA, Kurmus O, Kara O, Timur H, Gencosmanoglu G & Danisman N (2016). Novel indexes of arrhythmogenesis in preeclampsia: QT dispersion, Tp-e interval, and Tp-e/QT ratio. Pregnancy Hypertens 6, 38-41.
    1. Kishimoto T, Maekawa M, Abe Y & Yamamoto K (1973). Intrarenal distribution of blood flow and renin release during renal venous pressure elevation. Kidney Int 4, 259-266.
    1. Kwiatkowski S, Dołegowska B, Kwiatkowska E, Rzepka R, Marczuk N, Loj B & Torbè A (2017). Maternal endothelial damage as a disorder shared by early preeclampsia, late preeclampsia and intrauterine growth restriction. J Perinat Med 45, 793-802.
    1. Lafayette RA, Druzin M, Sibley R, Derby G, Malik T, Huie P, Polhemus C, Deen WM & Myers BD (1998). Nature of glomerular dysfunction in pre-eclampsia. Kidney Int 54, 1240-1249.
    1. Lanssens D, Smeets CJP, Vandervoort P, Grieten L & Gyselaers W (2018). Intrathoracic fluid changes from preconception to postpartum as measured by bio-impedance monitoring. J Matern Fetal Neonatal Med 30, 1-3.
    1. Lau ES & Sarma A (2017). The role of cardiac biomarkers in pregnancy. Curr Treat Options Cardiovasc Med 19, 49.
    1. Le Jemtel TH, Rajapreyar I, Selby MG, Payne B, Barnidge DR, Milic N & Garovic VD (2015). Direct evidence of podocyte damage in cardiorenal syndrome type 2: preliminary evidence. Cardiorenal Med 5, 125-134.
    1. León-Reyes G, Maida-Claros RF, Urrutia-Medina AX, Jorge-Galarza E, Guzmán-Grenfell AM, Fuentes-García S, Medina-Navarro R, Moreno-Eutimio MA, Muñoz-Sánchez JL, Hicks JJ & Torres-Ramos YD (2017). Oxidative profiles of LDL and HDL isolated from women with preeclampsia. Lipids Health Dis 16, 90.
    1. Leslie K, Whitley GS, Herse F, Dechend R, Ashton SV, Laing K, Thilaganathan B & Cartwright JE (2015). Increased apoptosis, altered oxygen signaling, and antioxidant defenses in first-trimester pregnancies with high-resistance uterine artery blood flow. Am J Pathol 185, 2731-2741.
    1. Levario-Carrillo M, Avitia M, Tufiño-Olivares E, Trevizo E, Corral-Terrazas M & Reza-López S (2006). Body composition of patients with hypertensive complications during pregnancy. Hypertens Pregnancy 25, 259-269.
    1. Lima PD, Zhang J, Dunk C, Lye SJ & Croy BA (2014). Leukocyte driven-decidual angiogenesis in early pregnancy. Cell Mol Immunol 11, 522-537.
    1. Lin S, Shimizu I, Suehara N, Nakayama M & Aono T (1995). Uterine artery Doppler velocimetry in relation to trophoblast migration into the myometrium of the placental bed. Obstet Gynecol 85, 760-765.
    1. Liszewski MK & Atkinson JP (2011). Too much of a good thing at the site of tissue injury: the instructive example of the complement system predisposing to thrombotic microangiopathy. Hematology Am Soc Hematol Educ Program 2011, 9-14.
    1. Lokki AI, Daly E, Triebwasser M, Kurki MI, Roberson EDO, Häppölä P, Auro K, Perola M, Heinonen S, Kajantie E, Kere J, Kivinen K, Pouta A, Salmon JE, Meri S, Daly M, Atkinson JP & Laivuori H (2017). Protective low-frequency variants for preeclampsia in the fms related tyrosine kinase 1 gene in the finnish population. Hypertension 70, 365-371.
    1. Lotgering FK & Wallenburg HC (1986). Hemodynamic effects of caval and uterine venous occlusion in pregnant sheep. Am J Obstet Gynecol 155, 1164-1170.
    1. Lu KJ, Kearney LG, Hare DL, Ord M, Toia D, Jones E, Burrell LM & Srivastava PM (2013). Cardiorenal anemia syndrome as a prognosticator for death in heart failure. Am J Cardiol 111, 1187-1191.
    1. Lumbers ER & Pringle KG (2014). Roles of the circulating renin-angiotensin-aldosterone system in human pregnancy. Am J Physiol Regul Integr Comp Physiol 306, R91-R101.
    1. Macdonald-Wallis C, Lawlor DA, Fraser A, May M, Nelson SM & Tilling K (2012). Blood pressure change in normotensive, gestational hypertensive, preeclamptic, and essential hypertensive pregnancies. Hypertension 59, 1241-1248.
    1. McGinnis R, Steinthorsdottir V, Williams NO, Thorleifsson G, Shooter S, Hjartardottir S, Bumpstead S, Stefansdottir L, Hildyard L, Sigurdsson JK, Kemp JP, Silva GB, Thomsen LCV, Jääskeläinen T, Kajantie E, Chappell S, Kalsheker N, Moffett A, Hiby S, Lee WK, Padmanabhan S, Simpson NAB, Dolby VA, Staines-Urias E, Engel SM, Haugan A, Trogstad L, Svyatova G, Zakhidova N, Najmutdinova D; FINNPEC Consortium; GOPEC Consortium, Dominiczak AF, Gjessing HK, Casas JP, Dudbridge F, Walker JJ, Pipkin FB, Thorsteinsdottir U, Geirsson RT, Lawlor DA, Iversen AC, Magnus P, Laivuori H, Stefansson K & Morgan L (2017). Variants in the fetal genome near FLT1 are associated with risk of preeclampsia. Nat Genet 49, 1255-1260.
    1. Machnik A, Neuhofer W, Jantsch J, Dahlmann A, Tammela T, Machura K, Park JK, Beck FX, Müller DN, Derer W, Goss J, Ziomber A, Dietsch P, Wagner H, van Rooijen N, Kurtz A, Hilgers KF, Alitalo K, Eckardt KU, Luft FC, Kerjaschki D & Titze J (2009). Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat Med 15, 545-552.
    1. Mahendru AA, Everett TR, McEniery CM, Wilkinson IB & Lees CC (2013). The feasibility of prospectively studying maternal cardiovascular changes from before conception. Hypertens Res 36, 698-704.
    1. Maisel AS, Katz N, Hillege HL, Shaw A, Zanco P, Bellomo R, Anand I, Anker SD, Aspromonte N, Bagshaw SM, Berl T, Bobek I, Cruz DN, Daliento L, Davenport A, Haapio M, House AA, Mankad S, McCullough P, Mebazaa A, Palazzuoli A, Ponikowski P, Ronco F, Sheinfeld G, Soni S, Vescovo G, Zamperetti N & Ronco C; Acute Dialysis Quality Initiative consensus group (2011). Biomarkers in kidney and heart disease. Nephrol Dial Transplant 26, 62-74.
    1. Maluso P, Olson J & Sarani B (2016). Abdominal compartment hypertension and abdominal compartment syndrome. Crit Care Clin 32, 213-222.
    1. Matsubara S (2018). Pre-pregnancy cardiovascular indices and birth outcomes of subsequent pregnancies: a ‘sequential stress test’ revealing hidden cardiovascular weakness? BJOG 125, 1135.
    1. Meah VL, Backx K & Davenport MH; International Working Group on Maternal Hemodynamics (2018). Functional hemodynamic testing in pregnancy: recommendations of the International Working Group on Maternal Hemodynamics. Ultrasound Obstet Gynecol 51, 331-340.
    1. Melchiorre K, Sharma R, Khalil A & Thilaganathan B (2016). Maternal cardiovascular function in normal pregnancy: evidence of maladaptation to chronic volume overload. Hypertension 67, 754-762.
    1. Melchiorre K, Sharma R & Thilaganathan B (2014). Cardiovascular implications in preeclampsia: an overview. Circulation 130, 703-714.
    1. Melchiorre K, Sutherland GR, Liberati M & Thilaganathan B (2011). Preeclampsia is associated with persistent postpartum cardiovascular impairment. Hypertension 58, 709-715.
    1. Mesens T, Tomsin K, Oben J, Staelens A & Gyselaers W (2015). Maternal venous hemodynamics assessment for prediction of preeclampsia should be longitudinal. J Matern Fetal Neonatal Med 28, 311-315.
    1. Mesens T, Tomsin K, Staelens AS, Oben J, Molenberghs G & Gyselaers W (2014). Is there a correlation between maternal venous hemodynamic dysfunction and proteinuria of preeclampsia? Eur J Obstet Gynecol Reprod Biol 181, 246-250.
    1. Monteith C, McSweeney L, Breatnach CR, Doherty A, Shirren L, Tully EC, Dicker P, Malone FD, El-Khuffash A & Kent E (2017). Non-invasive cardiac output monitoring (NICOM®) can predict the evolution of uteroplacental disease-results of the prospective HANDLE study. Eur J Obstet Gynecol Reprod Biol 216, 116-124.
    1. Mordel N, Birkenfeld A, Rubinger D, Schenker JG & Sadovsky E (1993). Successful full-term pregnancy in familial Mediterranean fever complicated with amyloidosis: case report and review of the literature. Fetal Diagn Ther 8, 129-134.
    1. Mühlberger I, Mönks K, Fechete R, Mayer G, Oberbauer R, Mayer B & Perco P (2012). Molecular pathways and crosstalk characterizing the cardiorenal syndrome. OMICS 16, 105-112.
    1. Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC, Young JB & Tang WHW (2009). Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 53, 589-596.
    1. Mullens W, Abrahams Z, Skouri HN, Francis GS, Taylor DO, Starling RC, Paganini E & Tang WH (2008). Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function? J Am Coll Cardiol 51, 300-306.
    1. Nakashima H, Katayama T, Honda Y, Suzuki S & Yano K (2004). Cardioprotective effects of magnesium sulfate in patients undergoing primary coronary angioplasty for acute myocardial infarction. Circ J 68, 23-28.
    1. Namugowa A, Iputo J, Wandabwa J, Meeme A & Buga GAB (2017). Comparison of arterial stiffness in preeclamptic and normotensive pregnant women from a semi-rural region of South Africa. Clin Exp Hypertens 39, 277-283.
    1. Napoli C, Casamassimi A, Crudele V, Infante T & Abbondanza C (2011). Kidney and heart interactions during cardiorenal syndrome: a molecular and clinical pathogenic framework. Future Cardiol 7, 485-497.
    1. Nejabati HR, Latifi Z, Ghasemnejad T, Fattahi A & Nouri M (2017). Placental growth factor (PlGF) as an angiogenic/inflammatory switcher: lesson from early pregnancy losses. Gynecol Endocrinol 33, 668-674.
    1. Ness RB & Roberts JM (1996). Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications. Am J Obstet Gynecol 175, 1365-1370.
    1. Nohria A, Hasselblad V, Stebbins A, Pauly DF, Fonarow GC, Shah M, Yancy CW, Califf RM, Stevenson LW & Hill JA (2008). Cardiorenal interactions: insights from the ESCAPE trial. J Am Coll Cardiol 51, 1268-1274.
    1. Oben J, Tomsin K, Mesens T, Staelens A, Molenberghs G & Gyselaers W (2014). Maternal cardiovascular profiling in the first trimester of pregnancies complicated with gestation-induced hypertension or fetal growth retardation: a pilot study. J Matern Fetal Neonatal Med 27, 1646-1651.
    1. Ohuchi H, Ikado H, Noritake K, Miyazaki A, Yasuda K & Yamada O (2013). Impact of central venous pressure on cardiorenal interactions in adult patients with congenital heart disease after biventricular repair. Congenit Heart Dis 8, 103-110.
    1. Palei AC, Spradley FT, Warrington JP, George EM & Granger JP (2013). Pathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiology. Acta Physiol (Oxf) 208, 224-233.
    1. Paulus BM, Ali S, Zia AA, Munir A, Davis RC Jr, Mansbach CM, Smith WC & Weber KT (2008). Causes and consequences of systemic venous hypertension. Am J Med Sci 336, 489-497.
    1. Perloff JK (1993). Systemic complications of cyanosis in adults with congenital heart disease. Hematologic derangements, renal function, and urate metabolism. Cardiol Clin 11, 689-699.
    1. Perry H, Khalil A & Thilaganathan B (2018a). Preeclampsia and the cardiovascular system: an update. Trends Cardiovasc Med 28, 505-513.
    1. Perry H, Lehmann H, Mantovani E, Thilaganathan B & Khalil A (2018b). Correlation between central and uterine haemodynamics in hypertensive disorders of pregnancy. Ultrasound Obstet Gynecol 54, 58-63.
    1. Perry H, Stirrup O, Gutierrez J, Vinayagam D, Thilaganathan B & Khalil A (2018c). Influence of maternal characteristics and gestational age on haemodynamic indices: NICOM device-specific reference ranges. Ultrasound Obstet Gynecol . [Epub ahead of print].
    1. Piccoli GB, Zakharova E, Attini R, Ibarra Hernandez M, Orozco Guillien A, Alrukhaimi M, Liu ZH, Ashuntantang G, Covella B, Cabiddu G, Li PKT, Garcia-Garcia G & Levin A (2018). Pregnancy in chronic kidney disease: need for higher awareness. A pragmatic review focused on what could be improved in the different CKD stages and phases. J Clin Med 7, E415.
    1. Prabhu SD (2004). Cytokine-induced modulation of cardiac function. Circ Res 95, 1140-1153.
    1. Prakash J & Ganiger VC (2017). Acute kidney injury in pregnancy-specific disorders. Indian J Nephrol 27, 258-270.
    1. Prefumo F, Sebire NJ & Thilaganathan B (2004). Decreased endovascular trophoblast invasion in first trimester pregnancies with high-resistance uterine artery Doppler indices. Hum Reprod 19, 206-209
    1. Pryde PG & Mittendorf R (2009). Contemporary usage of obstetric magnesium sulfate: indication, contraindication, and relevance of dose. Obstet Gynecol 114, 669-673.
    1. Raffaelli R, Prioli MA, Parissone F, Prati D, Carli M, Bergamini C, Cacici G, Balestreri D, Vassanelli C & Franchi M (2014). Pre-eclampsia: evidence of altered ventricular repolarization by standard ECG parameters and QT dispersion. Hypertens Res 37, 984-988.
    1. Rauchhaus M, Doehner W, Francis DP, Davos C, Kemp M, Liebenthal C, Niebauer J, Hooper J, Volk HD, Coats AJ & Anker SD (2000). Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 102, 3060-3067.
    1. Redman C (2014). Pre-eclampsia: a complex and variable disease. Pregnancy Hypertens 4, 241-242.
    1. Redman CW & Sargent IL (2005). Latest advances in understanding preeclampsia. Science 308, 1592-1594.
    1. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy (2000). Am J Obstet Gynecol 183, S1-S22.
    1. Reuter DG, Law Y, Levy WC, Seslar SP, Zierler RE, Ferguson M, Chattra J, McQuinn T, Liu LL, Terry M, Coffey PS, Dimer JA, Hanevold C, Flynn JT & Stapleton FB (2016). Can preeclampsia be considered a renal compartment syndrome? A hypothesis and analysis of the literature. J Am Soc Hypertens 10, 891-899.
    1. Robertson SA, Care AS & Moldenhauer LM (2018). Regulatory T cells in embryo implantation and the immune response to pregnancy. J Clin Invest 128, 4224-4235.
    1. Robson JS (1976). Proteinuria and the renal lesion in preeclampsia and abruptio placentae. Perspect Nephrol Hypertens 5, 61-73.
    1. Ronco C, House AA & Haapio M (2008). Cardiorenal syndrome: refining the definition of a complex symbiosis gone wrong. Intensive Care Med 34, 957-962.
    1. Ronco C & Maisel A (2010). Volume overload and cardiorenal syndromes. Congest Heart Fail 16, Si-Siv; quiz Svi.
    1. Roobottom CA, Hunter JD, Weston MJ & Dubbins PA (1995). Hepatic venous Doppler waveforms: changes in pregnancy. J Clin Ultrasound 23, 477-482.
    1. Salas SP, Marshall G, Gutiérrez BL & Rosso P (2006). Time course of maternal plasma volume and hormonal changes in women with preeclampsia or fetal growth restriction. Hypertension 47, 203-208.
    1. Sandgren JA, Scroggins SM, Santillan DA, Devor EJ, Gibson-Corley KN, Pierce GL, Sigmund CD, Santillan MK & Grobe JL (2015). Vasopressin: the missing link for preeclampsia? Am J Physiol Regul Integr Comp Physiol 309, R1062-R1064.
    1. Sawchuck DJ & Wittmann BK (2014). Pre-eclampsia renamed and reframed: Intra-abdominal hypertension in pregnancy. Med Hypotheses 83, 619-632.
    1. Scheuer J & Stezoski W (1973). The effects of uremic compounds on cardiac function and metabolism. J Mol Cell Cardiol 5, 287-300.
    1. Schlembach D (2003). Pre-eclampsia - still a disease of theories. Fukushima J Med Sci 49, 69-115.
    1. Schrier RW & Briner VA (1991). Peripheral arterial vasodilation hypothesis of sodium and water retention in pregnancy: implications for pathogenesis of preeclampsia-eclampsia. Obstet Gynecol 77, 632-639.
    1. Sep SJ, Schreurs MP, Bekkers SC, Kruse AJ, Smits LJ & Peeters LL (2011). Early-pregnancy changes in cardiac diastolic function in women with recurrent pre-eclampsia and in previously pre-eclamptic women without recurrent disease. BJOG 118, 1112-1119.
    1. Shamseddin MK & Parfrey PS (2009). Mechanisms of the cardiorenal syndromes. Nat Rev Nephrol 5, 641-649.
    1. Shih T, Peneva D, Xu X, Sutton A, Triche E, Ehrenkranz RA, Paidas M & Stevens W (2016). The rising burden of preeclampsia in the United States impacts both maternal and child health. Am J Perinatol 33, 329-338.
    1. Silber S (1999). Nitrates: why and how should they be used today? Current status of the clinical usefulness of nitroglycerin, isosorbide dinitrate and isosorbide-5-mononitrate. Eur J Clin Pharmacol 38, S35-S51.
    1. Sitras V, Paulssen RH, Grønaas H, Leirvik J, Hanssen TA, Vårtun A & Acharya G (2009). Differential placental gene expression in severe preeclampsia. Placenta 30, 424-433.
    1. Smeets CJ, Lanssens D, Gyselaers W, Bertrand PB, Grieten L & Vandervoort P (2016). Detection of subclinical transient fluid accumulation during pregnancy in a patient with an implantable cardioverter defibrillator and OptiVol® fluid monitoring algorithm. Int J Cardiol 214, 163-165.
    1. Spinillo A, Beneventi F, Caporali R, Ramoni V & Montecucco C (2017). Undifferentiated connective tissue diseases and adverse pregnancy outcomes. An undervalued association? Am J Reprod Immunol 78, 12762.
    1. Spracklen CN, Saftlas AF, Triche EW, Bjonnes A, Keating B, Saxena R, Breheny PJ, Dewan AT, Robinson JG, Hoh J & Ryckman KK (2015). Genetic predisposition to dyslipidemia and risk of preeclampsia. Am J Hypertens 28, 915-923.
    1. Spracklen CN, Smith CJ, Saftlas AF, Robinson JG & Ryckman KK (2014). Maternal hyperlipidemia and the risk of preeclampsia: a meta-analysis. Am J Epidemiol 180, 346-958.
    1. Stawicki SP, Papadimos TJ, Bahner DP, Evans DC & Jones C (2016). Correlations between pulmonary artery pressures and inferior vena cava collapsibility in critically ill surgical patients: an exploratory study. Int J Crit Illn Inj Sci 6, 194-199.
    1. Steegers EA, von Dadelszen P, Duvekot JJ & Pijnenborg R (2010). Pre-eclampsia. Lancet 376, 631-644.
    1. Stergiotou I, Crispi F, Valenzuela-Alcaraz B, Bijnens B & Gratacos E (2013). Patterns of maternal vascular remodeling and responsiveness in early- versus late-onset preeclampsia. Am J Obstet Gynecol 209, 558.e1-558.e14.
    1. Stevenson LW & Perloff JK (1989). The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA 261, 884-888.
    1. Stillman IE & Karumanchi SA (2007). The glomerular injury of preeclampsia. J Am Soc Nephrol 18, 2281-2284.
    1. Sugerman HJ (2011). Hypothesis: preeclampsia is a venous disease secondary to an increased intra-abdominal pressure. Med Hypotheses 77, 841-849.
    1. Suzuki H, Watanabe Y, Arima H, Kobayashi K, Ohno Y & Kanno Y (2008). Short- and long-term prognosis of blood pressure and kidney disease in women with a past history of preeclampsia. Clin Exp Nephrol 12, 102-109.
    1. Tamás P, Hantosi E, Farkas B, Ifi Z, Betlehem J & Bódis J (2017). Preliminary study of the effects of furosemide on blood pressure during late-onset pre-eclampsia in patients with high cardiac output. Int J Gynaecol Obstet 136, 87-90.
    1. Tay J, Foo L, Masini G, Bennett PR, McEniery CM, Wilkinson IB & Lees CC (2018). Early and late preeclampsia are characterized by high cardiac output, but in the presence of fetal growth restriction, cardiac output is low: insights from a prospective study. Am J Obstet Gynecol 218, 517.e1-517.e12.
    1. Teragawa H, Kato M, Yamagata T, Matsuura H & Kajiyama G (2000). The preventive effect of magnesium on coronary spasm in patients with vasospastic angina. Chest 118, 1690-1695.
    1. Testani JM, Khera AV, St John Sutton MG, Keane MG, Wiegers SE, Shannon RP & Kirkpatrick JN (2010). Effect of right ventricular function and venous congestion on cardiorenal interactions during the treatment of decompensated heart failure. Am J Cardiol 105, 511-516.
    1. Thilaganathan B (2018a). Pre-eclampsia and the cardiovascular-placental axis. Ultrasound Obstet Gynecol 51, 714-717.
    1. Thilaganathan B (2018b). Ultrasound fetal weight estimation at term may do more harm than good. Ultrasound Obstet Gynecol 52, 5-8.
    1. Thilaganathan B & Kalafat E (2019). Cardiovascular system in preeclampsia and beyond. Hypertension 73, 522-531
    1. Thornton C, Dahlen H, Korda A & Hennessy A (2013). The incidence of preeclampsia and eclampsia and associated maternal mortality in Australia from population-linked datasets: 2000-2008. Am J Obstet Gynecol 208, 476.e1-476.e5.
    1. Timur H, Daglar HK, Kara O, Kirbas A, Inal HA, Turkmen GG, Yilmaz Z, Elmas B & Uygur D (2016). A study of serum Apo A-1 and Apo B-100 levels in women with preeclampsia. Pregnancy Hypertens 6, 121-125.
    1. Touyz RM (2003). Role of magnesium in the pathogenesis of hypertension. Mol Aspects Med 24, 107-136.
    1. Trevisan R, Dodesini AR, Lepore G (2006). Lipids and renal disease. J Am Soc Nephrol 17, S145-S147.
    1. Tuten A, Erman H, Korkmaz GG, Oncul M, Gelisgen R, Sozer V, Acıkgoz S, Simsek G & Uzun H (2014). Comparison of maternal and umbilical cord blood soluble lectin-like oxidized low-density lipoprotein receptor 1 levels in early- and late-onset preeclampsia. Arch Gynecol Obstet 290, 1007-1013.
    1. Tuten A, Oncul M, Kucur M, Imamoglu M, Ekmekci OB, Acıkgoz AS, Cebe FS, Yesilbas C & Madazlı R (2015). Maternal serum copeptin concentrations in early- and late-onset pre-eclampsia. Taiwan J Obstet Gynecol 54, 350-354.
    1. Uma R, Forsyth SJ, Struthers AD, Fraser CG, Godfrey V & Murphy DJ (2010). Polymorphisms of the angiotensin converting enzyme gene in early-onset and late-onset pre-eclampsia. J Matern Fetal Neonatal Med 23, 874-879.
    1. Valensise H, Vasapollo B, Gagliardi G & Novelli GP (2008a). Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease. Hypertension 52, 873-880.
    1. Valensise H, Vasapollo B, Novelli GP, Giorgi G, Verallo P, Galante A & Arduini D (2008b). Maternal and fetal hemodynamic effects induced by nitric oxide donors and plasma volume expansion in pregnancies with gestational hypertension complicated by intrauterine growth restriction with absent end-diastolic flow in the umbilical artery. Ultrasound Obstet Gynecol 31, 55-64.
    1. van Drongelen J, de Vries R, Lotgering FK, Smits P & Spaanderman ME (2014). Functional vascular changes of the kidney during pregnancy in animals: a systematic review and meta-analysis. PLoS One 9, e112084.
    1. van Hagen IM, Roos-Hesselink JW, Donvito V, Liptai C, Morissens M, Murphy DJ, Galian L, Bazargani NM, Cornette J, Hall R & Johnson MR (2017). Incidence and predictors of obstetric and fetal complications in women with structural heart disease. Heart 103, 1610-1618.
    1. Vasapollo B, Novelli GP, Gagliardi G, Tiralongo GM, Pisani I, Manfellotto D, Giannini L & Valensise H (2012). Medical treatment of early-onset mild gestational hypertension reduces total peripheral vascular resistance and influences maternal and fetal complications. Ultrasound Obstet Gynecol 40, 325-331.
    1. Veena P, Perivela L & Raghavan SS (2017). Furosemide in postpartum management of severe preeclampsia: A randomized controlled trial. Hypertens Pregnancy 36, 84-89.
    1. Vellanki K (2013). Pregnancy in chronic kidney disease. Adv Chronic Kidney Dis 20, 223-228.
    1. Verlohren S, Melchiorre K, Khalil A & Thilaganathan B (2014). Uterine artery Doppler, birth weight and timing of onset of pre-eclampsia: providing insights into the dual etiology of late-onset pre-eclampsia. Ultrasound Obstet Gyneco 44, 293-298.
    1. Vesely SK (2015). Life after acquired thrombotic thrombocytopenic purpura: morbidity, mortality, and risks during pregnancy. J Thromb Haemost 13, S216-S222.
    1. Vinayagam D, Patey O, Thilaganathan B & Khalil A (2017). Cardiac output assessment in pregnancy: comparison of two automated monitors with echocardiography. Ultrasound Obstet Gynecol 49, 32-38.
    1. Vinayagam D, Thilaganathan B, Stirrup O, Mantovani E & Khalil A (2018). Maternal hemodynamics in normal pregnancy: reference ranges and role of maternal characteristics. Ultrasound Obstet Gynecol 51, 665-671.
    1. Virzì GM, Clementi A, de Cal M, Brocca A, Day S, Pastori S, Bolin C, Vescovo G & Ronco C (2015). Oxidative stress: dual pathway induction in cardiorenal syndrome type 1 pathogenesis. Oxid Med Cell Longev 2015, 391790.
    1. Virzì GM, Clementi A, Brocca A, de Cal M & Ronco C (2016). Molecular and genetic mechanisms involved in the pathogenesis of cardiorenal cross talk. Pathobiology 83, 201-210.
    1. Vonck S, Oben J, Staelens AS, Lanssens D, Molenberghs G & Gyselaers W (2017). Optimization of simple sphygmomanometric blood pressure measurement in routine prenatal care. Health Care Current Reviews 5, 185.
    1. von Dadelszen P, Magee LA & Roberts JM (2003). Subclassification of preeclampsia. Hypertens Pregnancy 22, 143-148.
    1. von Dadelszen P, Menzies J, Gilgoff S, Xie F, Douglas MJ, Sawchuck D & Magee LA (2007). Evidence-based management for preeclampsia. Front Biosci 12, 2876-2889.
    1. Wallace AE, Whitley GS, Thilaganathan B & Cartwright JE (2015). Decidual natural killer cell receptor expression is altered in pregnancies with impaired vascular remodeling and a higher risk of pre-eclampsia. J Leukoc Biol 97, 79-86.
    1. Whaley-Connell A & Sowers JR (2014). Basic science: Pathophysiology: the cardiorenal metabolic syndrome. J Am Soc Hypertens 8, 604-606.
    1. Widen EM & Gallagher D (2014). Body composition changes in pregnancy: measurement, predictors and outcomes. Eur J Clin Nutr 68, 643-652.
    1. Wu P, Haththotuwa R, Kwok CS, Babu A, Kotronias RA, Rushton C, Zaman A, Fryer AA, Kadam U, Chew-Graham CA & Mamas MA (2017). Preeclampsia and future cardiovascular health: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes 10 e003497.
    1. Xia Y, Zhou CC, Ramin SM & Kellems RE (2007). Angiotensin receptors, autoimmunity, and preeclampsia. J Immunol 179, 3391-3395.
    1. Yan JY & Jiang LL (2015). Expression of advanced glycation end products in placenta and concentration in maternal and umbilical serum in pre-eclampsia. J Obstet Gynaecol Res 41, 843-849
    1. Yasuda R, Takeuchi K, Funakoshi T & Maruo T (2003). Bioelectrical impedance analysis in the clinical management of preeclamptic women with edema. J Perinat Med 31, 275-280.
    1. Zoccali C (2007). The endothelium as a target in renal diseases. J Nephrol 20, S39-S44.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj